- Home
- AVTX vs PHK Comparison
AVTX vs PHK Comparison
Compare AVTX & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$16.51
Company Overview
Basic Information| Metric | AVTX | PHK |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | United States | United States |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.6M | 852.2M |
| IPO Year | 2015 | 2003 |
Fundamental Metrics
Financial Performance| Metric | AVTX | PHK |
|---|---|---|
| Price | $16.51 | $4.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $40.57 | N/A |
| AVG Volume (30 Days) | 856.9K | ★ 996.2K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $10.70 | $4.23 |
| 52 Week High | $24.27 | $5.00 |
Technical Indicators
Market Signals| Indicator | AVTX | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 24.38 |
| Support Level | $15.29 | N/A |
| Resistance Level | $16.80 | $4.73 |
| Average True Range (ATR) | 1.00 | 0.06 |
| MACD | -0.20 | -0.02 |
| Stochastic Oscillator | 23.14 | 1.35 |
Price Performance
Historical Comparison AVTX
PHK
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. The secondary objective of the company is to seek capital appreciation.